Corsens Medical

Company Overview

Snapshot

Founded in August 2013 by Alon Marmor, Corsens Medical operates with 1–10 employees. The company received US FDA clearance for its 510(k) Pre-Marketing Notification for its cardiac monitor in November 2016.

Business overview

Corsens Medical develops a lightweight, simple-to-operate, early-warning cardiac alert monitor for home use. The company's core technology focuses on real-time sensing to provide early detection and remote monitoring capabilities. It serves the healthcare industry, specifically providers, within the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Patient Remote Monitoring.

Strategic signal

In November 2016, Corsens Medical secured US FDA clearance for its 510(k) Pre-Marketing Notification for its cardiac monitor. This regulatory approval was a critical validation for the company's technology, signaling its readiness for commercialization and potential market entry in the United States, and demonstrating the device's safety and effectiveness to investors and the medical community.

Company Intelligence Q&A

What is Corsens Medical's primary product?

Corsens Medical has developed a lightweight, simple-to-operate, early-warning cardiac alert monitor designed for home use.

When did Corsens Medical receive FDA clearance for its cardiac monitor?

In November 2016, Corsens Medical's cardiac monitor was granted US FDA clearance for 510(k) Pre-Marketing Notification.

When did Corsens Medical file its 510(k) Pre-Marketing Notification with the US FDA?

Corsens Medical filed its 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor in May 2016.

Who is a co-founder of Corsens Medical?

Alon Marmor is a co-founder and Director of Medical Affairs at Corsens Medical.

What is the current status of Corsens Medical?

Corsens Medical is currently non-active, having ceased to operate in April 2026.